Overview

Androgen Regulation of Priapism in Sickle Cell Disease

Status:
Withdrawn
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
It is believed that when androgen (testosterone) levels are below normal there is a disturbance of normal bodily functioning that is associated with priapism in some men. Conversely, it is believed that testosterone replacement will improve the condition of priapism when the testosterone levels are brought to normal. In turn, this will also improve psychological well being in men with sickle cell disease (SCD).
Phase:
Early Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Androgens
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate